Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q2 2023 call → NOWe need to determine if the transcript describes a situation where the company is currently paying for something not yet earning, with a specific near-dated event that ends the wait, and management treats this as the main current work. Let's analyze. The transcript discusses: new store openings (3 this year, 10 next year, 15-20 in 2025), brand awareness investments, marketing increases, loyalty program changes, etc. But the question is about a specific waiting period where the company is paying costs now for something not yet earning, and the end is near-dated and already visible. Management talks about investing in marketing and brand building, but that's ongoing. They mention new stores opening later this year, but those are not yet open. However, they are not described as a burden or a cost currently being absorbed with a specific end date. They are just future openings. The key is: Is there a specific cost being incurred now for something that will start earning soon? For example, they mention "we are close to completing six conversions casual male XL stores to DXL" and "we expect to complete four more by the end of 2023." But that's not a cost being paid now for future benefit; it's a conversion process. They also mention "we've begun work on our lab concept, remodeling" and "we expect to begin work shortly on one of our DXL stores in the Chicago market" - but again, that's not a defined waiting period. The question asks: "does management describe the company as CURRENTLY LIVING THROUGH A DEFINED WAITING PERIOD IT IS PAYING FOR OUT OF ITS OWN POCKET" - meaning they are paying costs now for something that will start earning later. The transcript does mention that they are investing in marketing and brand awareness, but that's not a specific event with a near-dated end. They also mention new store openings, but those are not yet open, and the costs of opening them are not described as a burden. Management does say: "We are faced with the prospect of being a $550 million to $600 million company at 12.5% EBITDA or aiming higher and emerging over the next three to five years with -- for now with a significantly greater top line and greater scale to then leverage our operating model." That's a strategic choice, not a specific waiting period.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.